Auditory risk of hyperbilirubinemia in term newborns: A systematic review

International Journal of Pediatric Otorhinolaryngology

Volumn 77, Issue 6, 2013, Pages 898-905

  Akinpelu, Olubunmi Victoria ^a   Waissbluth, Sofia ^a   Daniel, Sam J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

ABR; Auditory brainstem evoked response; Auditory system; Hearing; HL; Jaundice; Neonatal hyperbilirubinemia; Newborns; TSB

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; DISEASE ASSOCIATION; EVOKED BRAIN STEM AUDITORY RESPONSE; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; HEARING; HEARING IMPAIRMENT; HEARING TEST; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

AUDIOMETRY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FOLLOW-UP STUDIES; HEARING LOSS, SENSORINEURAL; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; MALE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TERM BIRTH;

EID: 84877794930     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2013.03.029     Document Type: Review

References (73)

1. de Steuben C. Breast-feeding and jaundice: a review. J. Nurse Midwifery 1992, 37:59S-66S.
2. Gubernick J.A., Rosenberg H.K., Ilaslan H., Kessler A. US approach to jaundice in infants and children. Radiographics 2000, 20:173-195.
3. Johnson L. Yet another expert opinion on bilirubin toxicity. Pediatrics 1992, 89:829-831.
4. Ross G. Hyperbilirubinemia in the 2000s: what should we do next?. Am. J. Perinatol. 2003, 20:415-424.
5. Dijk P.H., Hulzebos C.V. An evidence-based view on hyperbilirubinaemia. Acta Paediatr. Suppl. 2012, 101:3-10.
6. Wolf M.J., Wolf B., Beunen G., Casaer P. Neurodevelopmental outcome at 1 year in Zimbabwean neonates with extreme hyperbilirubinaemia. Eur. J. Pediatr. 1999, 158:111-114.
7. Oh W., Tyson J.E., Fanaroff A.A., Vohr B.R., Perritt R., Stoll B.J., et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003, 112:773-779.
8. Wong V., Chen W.X., Wong K.Y. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J. Child Neurol. 2006, 21:309-315.
9. Newman T.B., Liljestrand P., Jeremy R.J., Ferriero D.M., Wu Y.W., Hudes E.S., et al. Outcomes among newborns with total serum bilirubin levels of 25mg per deciliter or more. N. Engl. J. Med. 2006, 354:1889-1900.
10. Heimler R., Sasidharan P. Neurodevelopmental and audiological outcome of healthy term newborns with moderately severe non-haemolytic hyperbilirubinemia. J. Paediatr. Child Health 2010, 46:588-591.
11. Zhang S., Wickesberg R.E., Oertel D. Jaundiced Gunn rats have increased synaptic delays in the ventral cochlear nucleus. Brain Res. 1989, 501:194-197.
12. Spencer R.F., Shaia W.T., Gleason A.T., Sismanis A., Shapiro S.M. Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat. Hear. Res. 2002, 171:129-141.
13. Shaia W.T., Shapiro S.M., Spencer R.F. The jaundiced Gunn rat model of auditory neuropathy/dyssynchrony. Laryngoscope 2005, 115:2167-2173.
14. Nakamura H., Takada S., Shimabuku R., Matsuo T., Negishi H. Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985, 75:703-708.
15. Deorari A.K., Singh M., Ahuja G.K., Bisht M.S., Verma A., Paul V.K., et al. One year outcome of babies with severe neonatal hyperbilirubinemia and reversible abnormality in brainstem auditory evoked responses. Indian Pediatr. 1994, 31:915-921.
16. Agrawal V.K., Shukla R., Misra P.K., Kapoor R.K., Malik G.K. Brainstem auditory evoked response in newborns with hyperbilirubinemia. Indian Pediatr. 1998, 35:513-518.
17. Alkalay A.L., Simmons C.F. Hyperbilirubinemia guidelines in newborn infants. Pediatrics 2005, 115:824-825.
18. Bhutani V.K., Maisels M.J., Stark A.R., Buonocore G., Expert Committee for Severe Neonatal Hyperbilirubinemia, European Society for Pediatric Research, et al. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants > or = 35 weeks gestation. Neonatology 2008, 94:63-67.
19. Kaplan M., Merlob P., Regev R. Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J. Perinatol. 2008, 28:389-397.
20. Academy of Breastfeeding Medicine Protocol Committee ABM clinical protocol #22: guidelines for management of jaundice in the breastfeeding infant equal to or greater than 35 weeks' gestation. Breastfeed. Med. 2010, 5:87-93.
21. Bhutani V.K., Vilms R.J., Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J. Perinatol. 2010, 30:S6-S15.
22. Schwartz H.P., Haberman B.E., Ruddy R.M. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr. Emerg. Care 2011, 27:884-889.
23. Sanpavat S. The use of clinical practice guideline on hyperbilirubinemia: rule or guideline. J. Med. Assoc. Thai. 2004, 87:1250-1252.
24. Fay D.L., Schellhase K.G., Suresh G.K. Bilirubin screening for normal newborns: a critique of the hour-specific bilirubin nomogram. Pediatrics 2009, 124:1203-1205.
25. Okwundu C.I., Okoromah C.A., Shah P.S. Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Cochrane Database Syst. Rev. 2012, 18:CD007966.
26. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297.
27. Newman T.B., Maisels M.J. Does hyperbilirubinemia damage the brain of healthy full-term infants?. Clin. Perinatol. 1990, 17:331-358.
28. Porter M.L., Dennis B.L. Hyperbilirubinemia in the term newborn. Am. Fam. Physician 2002, 65:599-601.
29. Skae M.S., Moise J., Clarke P. Is current management of neonatal jaundice evidence based?. Arch. Dis. Child. Fetal Neonatal Ed. 2005, 90:F540.
30. Johnson L., Bhutani V.K. The clinical syndrome of bilirubin-induced neurologic function. Semin. Perinatol. 2011, 35:101-113.
31. Boo N.Y., Oakes M., Lye M.S., Said H. Risk factors associated with hearing loss in term neonates with hyperbilirubinaemia. J. Trop. Pediatr. 1994, 40:194-197.
32. Sheykholeslami K., Kaga K. Otoacoustic emissions and auditory responses after neonatal hyperbilirubinemia. Int. J. Pediatr. Otorhinolaryngol. 2000, 52:65-73.
33. Bhutani V.K., Johnson L. Kernicterus: a preventable neonatal brain injury. J. Arab Neonatal Forum 2005, 2:12-24.
34. Zhou X., Liang Y., Li Q., Ouyang T.B., Tan M.L. Effects of hyperbilirubinemia on distortion product otoacoustic emission, auditory brainstem response and mismatch negativity in guinea pigs. Nan Fang Yi Ke Da Xue Xue Bao 2009, 29:768-771.
35. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998, 52:377-384.
36. Boreau T., Jolibois R.P., Roux F., Spassova K., Sureau C. [Reaction to calibrated auditory stimulation in neonatal jaundice]. Ann. Pediatr. (Paris) 1970, 17(2):130-140.
37. Coly P.I., Moreau J.C., Tending G., Diouf A., Diop E.M., Diadhiou F., et al. Test for detection of deafness in newborns at risk. Apropos of 1048 tests. Dakar Med. 1993, 38(2):133-137.
38. Huchet J., Moatti L., Pinon F., Dely L., André R., Eyries C. [Neonatal hyperbilirubinemia and hearing]. Arch. Fr. Pediatr. 1970, 27(February (2)):219.
39. Huchet J., Moatti L., Dely L. Neonatal hyperbilirubinemia and isolated hearing disorders. Tentative evaluation of the risk. Revue de Pediatrie 1973, 9(7):427-432.
40. Armas Ramos H., Hernández González R., Monserrat Gili J.R., Cardona Guerra P., González González N.L. [Neurosensory defects secondary to neonatal hyperbilirubinemia]. An. Esp. Pediatr. 1989, 30(3):166-170.
41. Claros P., Turcanu D., Caballero M., Costa C., Claveria M.A., Claros A., et al. Sensorineural hearing loss due to neonatal hyperbilirubinemia. Acta Otorrinolaringol. Esp. 2003, 54(6):393-398.
42. Singh K.B., Gupta A.K., Mann S.B., Naranq A. Comparative ABR profile in high risk infants. Auris Nasus Larynx 1998, 25:143-148.
43. AlOtaibi S.F., Blaser S., MacGregor D.L. Neurological complications of kernicterus. Can. J. Neurol. Sci. 2005, 32:311-315.
44. Guo X., Pu X., An T., Li Q., Qiu M., Wu Q., et al. Characteristics of brainstem auditory evoked potential of neonates with mild or moderate hyperbilirubinemia. Neural Regeneration Res. 2007, 2:660-664.
45. Ahlfors C.E., Parker A.E. Unbound bilirubin concentration is associated with abnormal automated auditory brainstem response for jaundiced newborns. Pediatrics 2008, 121:976-978.
46. Jiang Z.D., Brosi D.M., Wilkinson A.R. Changes in BAER wave amplitudes in relation to total serum bilirubin level in term neonates. Eur. J. Pediatr. 2009, 168:1243-1250.
47. Rhee C.K., Park H.M., Jang Y.L. Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses. Laryngoscope 1999, 109:2005-2008.
48. Sharma P., Chhangani N.P., Meena K.R., Jora R., Sharma N., Gupta B.D. Brainstem evoked response audiometry (BAER) in neonates with hyperbilirubinemia. Indian J. Pediatr. 2006, 73:413-416.
49. Chen W.X., Wong V.C., Wong K.Y. Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia. J. Child Neurol. 2006, 21:474-479.
50. Gupta A.K., Raj H., Anand N.K. Auditory brainstem responses (ABR) in neonates with hyperbilirubinemia. Indian J. Pediatr. 1990, 57:705-711.
51. Boo N.Y., Rohani A.J., Asma A. Detection of sensorineural hearing loss using automated auditory brainstem-evoked response and transient-evoked otoacoustic emission in term neonates with severe hyperbilirubinaemia. Singapore Med. J. 2008, 49:209-214.
52. Newton V. Adverse perinatal conditions and the inner ear. Semin. Neonatol. 2001, 6:543-551.
53. Katona G.G., Farkas Z., Reval K., Szabo M. Follow up studies of patients with neonatal icterus using acoustic evoked potential audiometry. Orv. Hetil. 1989, 130:1001-1004.
54. Baradaranfar M.H., Atighechi S., Dadgarnia M.H., Jafari R., Karimi G., Mollasadeghi A., et al. Hearing status in neonatal hyperbilirubinemia by auditory brainstem evoked response and transient evoked otoacoustic emissions. Acta Med. Iran. 2011, 49:109-112.
55. Scheidt P.C., Mellits E.D., Hardy J.B., Drage J.S., Boggs T.R. Toxicity to bilirubin in neonates. Infant development during the first year in relation to maximum neonatal serum bilirubin concentration. J. Pediatr. 1977, 91:292-297.
56. Funato M., Teraoka S., Tamai H., Shimida S. Follow-up study of auditory brainstem responses in hyperbilirubinemic newborns treated with exchange transfusion. Acta Paediatr. Jpn. 1996, 38:17-21.
57. van de Bor M., Ens-Dokkum M., Schreuder A.M., Veen S., Brand R., Verloove-Vanhorick S.P. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics 1992, 89:359-364.
58. Akman I., Ozek E., Kulekci S., Türkdogan D., Cebeci D., Akdaş F. Auditory neuropathy in hyperbilirubinemia: is there a correlation between serum bilirubin, neuron-specific enolase levels and auditory neuropathy?. Int. J. Audiol. 2004, 43:516-522.
59. de Vries L.S., Larry S., Dubowitz L.M. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985, 76:351-354.
60. Orkin S.H., Nathan D.G., Ginsburg D., Look A.T., Fisher D.E., Lux S.E. Nathan and Oski's Hematology of Infancy and Childhood 2009, Elsevier Health Sciences, Philadelphia, PA. 7th ed.
61. Amin S.B., Ahlfors C., Orlando M.S., Dalzell L.E., Merle K.S., Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 2001, 107:664-670.
62. Ahlfors C.E., Shapiro S.M. Auditory brainstem response and unbound bilirubin in jaundiced (jj) Gunn rat pups. Biol. Neonate 2001, 80:158-162.
63. Lee Y.K., Daito Y., Katayama Y., Minami H., Negishi H. The significance of measurement of unbound bilirubin concentrations in high-risk infants. Pediatr. Int. 2009, 51:795-799.
64. Wennberg R.P., Ahlfors C.E., Bhutani V.K., Johnson L.H., Shapiro S.M. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006, 117:474-485.
65. Celio M.R., Baier W., Scharer L., Gregersen H.J., de Viragh P.A., Norman A.W. Monoclonal antibodies directed against the calcium binding protein Calbindin D-28k. Cell Calcium 1990, 11:599-602.
66. Spencer R.F., Shaia W.T., Gleason A.T., Sismanis A., Shapiro S.M. Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rats. Hear. Res. 2002, 171:129-141.
67. Sharma V., Nag T.C., Wadhwa S., Roy T.S. Stereological investigation and expression of calcium-binding proteins in developing human inferior colliculus. J. Chem. Neuroanat. 2009, 37:78-86.
68. Hung K.L. Auditory brainstem responses in patients with neonatal hyperbilirubinemia and bilirubin encephalopathy. Brain Dev. 1989, 11:297-301.
69. Hansen T.W. Treatment of jaundice in the newborn infant - "many roads to Rome". Indian Pediatr. 2010, 47:396-397.
70. Yilmaz Y., Degirmenci S., Akdas F., Külekçi S., Ciprut A., Yüksel S., et al. Prognostic value of auditory brainstem response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J. Child Neurol. 2001, 16:772-775.
71. Clemens C.J., Davis S.A., Bailey A.R. The false-positive in universal newborn hearing screening. Pediatrics 2000, 106:1-5.
72. Eavey R.D. Abnormalities of the neonatal ear: otoscopic observations, histologic observations, and a model for contamination of the middle ear by cellular contents of amniotic fluid. Laryngoscope 1993, 103:1-31.
73. Chang K.W., Vohr B.R., Norton S.J., Lekas M.D. External and middle ear status related to evoked otoacoustic emission in neonates. Arch. Otolaryngol. Head Neck Surg. 1993, 119:276-282.